Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility

The purpose of this paper is to conduct a cost-effectiveness and cost-benefit analysis of this SIF using secondary data gathered and analysed in 2008.
Original research | 2010
Evidence base, Advocacy, Social benefits, SCS/OPS

Acceptability of, and barriers and facilitators to, a pilot physical health service for people who inject drugs: A qualitative study with service users and providers

This study explored the acceptability of, and barriers and facilitators to, embedding a pilot physical healthcare service within a community-based drug service in the United Kingdom (Bristol, England)
Original research | 2022
Wrap-around services, Social services, Barriers and enablers, Stigma

Addressing COVID-19 Among People Experiencing Homelessness: Description, Adaptation, and Early Findings of a Multiagency Response in Boston

Describes a city-wide COVID-19 care model for the homeless population
Case study | 2020
Harm reduction, Social services, Housing

Addressing the dual public health emergency: supporting physicians to prescribe opioid medications

Response to Tyndall 2020 (A safer drug supply…)
Letter | 2020
Hesitancy of prescribers , About prescribers

Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting

This study examines patient correlates of buprenorphine retention and whether an integrated, interdisciplinary treatment model (buprenorphine and behavioral health) is associated with higher odds of b
Original research | 2021
About prescribers, Outcomes, Substitution/OAT, Mental health

Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014–2020

In Canada, restrictions on BUP-NX prescribing were relaxed in 2016, which may have had an effect on rates of diversion and non-prescribed use.
Original research | 2022
Hesitancy of prescribers , About PWUD, Substitution/OAT, Diversion

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada

The current study examined how COVID-19 has impacted substance use supply and use characteristics among a national cohort of PWUD in Canada.
Original research | 2021
Overdose, Evidence base, Harm reduction, Policy/Regulatory, Safer supply, Advocacy, About PWUD

Development of a filter to prevent infections with spore-forming bacteria in injecting drug users

Our aim was to develop a filter that efficiently removes spore-forming bacteria and is also likely to be acceptable for use by people who inject drugs (i.e. quick, simple and not spoil the hit).
Original research | 2016
Harm reduction, Safer supply, About PWUD, Injecting drugs

Experiences with the Philadelphia police assisted diversion program: A qualitative study

Philadelphia launched a Police Assisted Diversion (PAD) program to address the highest rates of poverty, incarceration, and fatal overdose among large cities in the U.S.
Original research | 2022
Social services, Housing, Crime, Legal system/law enforcement, Illegal drugs

Harm Reduction at Work: A Guide for Organizations Employing People Who Use Drugs

The key goal of this guide is to help harm reduction organizations and drug policy advocates hire and work with active drug users

Guidelines | 2010
Policy/Regulatory, About PWUD, Workplace, Substitution/OAT, Peer/PWLLE program involvement, Harm reduction

Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma

For PWID, intersectional experiences of stigma and other social vulnerabilities may influence their experiences navigating medical care.
Original research | 2021
About pharmacists, About PWUD, Barriers and enablers, Poverty, Illegal drugs, Stigma

Injectable Opioid Agonist Treatment

Webpage | 2020
Safer supply, Advocacy

Investigating the impacts of COVID-19 among LGBTQ2S youth experiencing homelessness

this study aimed to understand the impacts of the COVID-19 pandemic on LGBTQ2S youth at risk of, and experiencing, homelessness in the Greater Toronto Area, Ontario, Canada and surrounding areas.
Original research | 2021
About PWUD, Housing, Youth, 2SLGBTQI+

Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters

To identify implementation barriers and facilitators to the adoption and implementation of programs that provide opioid agonist treatments (OAT) with methadone and buprenorphine to treat opioid use di
Original research | 2021
Safer supply, About prescribers, Legal system/law enforcement, Substitution/OAT

Moving the Dial on Safer Supply in Ontario

Experts running safer supply programs in Ontario provide an overview of their programs; program participants share experiences
Archived webinar | 2020
Safer supply, About prescribers, About PWUD

MySafe, Safe Supply and Drug Poisoning with Dr. Mark Tyndall

Dr. Mark Tyndall presents about MySafe - an innovative safe supply project which uses biometric dispensing technology to provide registered users with safe supply hydromophone
Archived webinar | 2020
Overdose, Safer supply

National trends in population rates of opioid-related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population-based study

We aimed to estimate Canadian national time trends in opioid-related mortality from 2000 to 2017 and opioid-related hospitalization and emergency department visits between 2000 and 2012.
Original research | 2021
Overdose, Mortality, Evidence base, Hospitals

Over 100 organizations endorse call for access to Emergency Safe Supply

Letter | 2020
Policy/Regulatory, Safer supply, Advocacy

Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting

This study sought to investigate the possible relationship between recent naturalistic psychedelic use and subsequent daily illicit opioid use among people who use drugs (PWUD).

Original research | 2022
About PWUD, Outcomes, Illegal drugs, Hallucinogens/psychedelics

Psychoactive Substance Use Policy

Alberta Health Services is committed to providing a patient-focused, quality health system that is accessible and sustainable for all Albertans.
Policy | 2020
Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Hospitals

Refine Your Search

Keywords
Format
Region